These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 27278063)
1. Effect of botulinum toxin treatment on quality of life in patients with isolated lingual dystonia and oromandibular dystonia affecting the tongue. Nastasi L; Mostile G; Nicoletti A; Zappia M; Reggio E; Catania S J Neurol; 2016 Sep; 263(9):1702-8. PubMed ID: 27278063 [TBL] [Abstract][Full Text] [Related]
2. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias. Rosales RL; Ng AR; Santos MM; Fernandez HH Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790 [TBL] [Abstract][Full Text] [Related]
4. Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features. Yoshida K Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30658420 [TBL] [Abstract][Full Text] [Related]
5. Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia. Adler CH; Factor SA; Brin M; Sethi KD Mov Disord; 2002 Jan; 17(1):158-61. PubMed ID: 11835455 [TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up. Tan EK; Jankovic J Neurology; 1999 Dec; 53(9):2102-7. PubMed ID: 10599789 [TBL] [Abstract][Full Text] [Related]
7. Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis. Dadgardoust PD; Rosales RL; Asuncion RM; Dressler D J Neural Transm (Vienna); 2019 Feb; 126(2):141-148. PubMed ID: 30604200 [TBL] [Abstract][Full Text] [Related]
8. Jaw-opening oromandibular dystonia secondary to Wilson's disease treated with botulinum toxin type A. Teive HA; Klüppel LE; Munhoz RP; Becker N; Müller PR; Werneck LC Arq Neuropsiquiatr; 2012 Jun; 70(6):407-9. PubMed ID: 22699536 [TBL] [Abstract][Full Text] [Related]
9. Assessment of Botulinum Neurotoxin Injection for Dystonic Hand Tremor: A Randomized Clinical Trial. Rajan R; Srivastava AK; Anandapadmanabhan R; Saini A; Upadhyay A; Gupta A; Vishnu VY; Pandit AK; Vibha D; Singh MB; Bhatia R; Goyal V; Dwivedi SN; Srivastava P; Prasad K JAMA Neurol; 2021 Mar; 78(3):302-311. PubMed ID: 33346814 [TBL] [Abstract][Full Text] [Related]
10. Effects of Botulinum Toxin Therapy on Health-Related Quality of Life Evaluated by the Oromandibular Dystonia Rating Scale. Yoshida K Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287925 [TBL] [Abstract][Full Text] [Related]
12. [Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition]. Budrewicz S; Koszewicz M; Góral M Neurol Neurochir Pol; 2003; 37 Suppl 5():55-60. PubMed ID: 15098332 [TBL] [Abstract][Full Text] [Related]
13. Multidisciplinary management of a partially edentulous patient with oromandibular dystonia: A clinical report. Sakar O; Matur Z; Mumcu Z; Sesen P; Oge E J Prosthet Dent; 2018 Aug; 120(2):173-176. PubMed ID: 29429838 [TBL] [Abstract][Full Text] [Related]
14. Self-Rated Communication-Related Quality of Life of Individuals With Oromandibular Dystonia Receiving Botulinum Toxin Injections. Page AD; Siegel L; Jog M Am J Speech Lang Pathol; 2017 Jun; 26(2S):674-681. PubMed ID: 28654948 [TBL] [Abstract][Full Text] [Related]
15. Jaw-opening dystonia: Quality of life after botulinum toxin injections. Charous SJ; Comella CL; Fan W Ear Nose Throat J; 2011 Feb; 90(2):E9. PubMed ID: 21328222 [TBL] [Abstract][Full Text] [Related]
16. Management of oromandibular dystonia with botulinum A toxin: a series of cases. Teemul TA; Patel R; Kanatas A; Carter LM Br J Oral Maxillofac Surg; 2016 Dec; 54(10):1080-1084. PubMed ID: 27776922 [TBL] [Abstract][Full Text] [Related]